Fuller Albright: Difference between revisions
| Line 15: | Line 15: | ||
==Illness and death== | ==Illness and death== | ||
He developed [[Parkinson's disease]] in 1937. By 1956 his symptoms were so intractable that he underwent experimental brain surgery, chemical | He developed [[Parkinson's disease]] in 1937. By 1956 his symptoms were so intractable that he underwent experimental brain surgery, chemical pallidectomy (obliteration of the [[globus pallidus]] by injection of [[ethanol|alcohol]]). The intervention on the right was a success, but the left-sided procedure was complicated by [[haemorrhage]], which left him [[aphasia|aphasic]] and comatose for the remaining 13 years of his life, during which he was nursed at Massachusetts General Hospital.<ref name=Leaf/> | ||
==References== | ==References== | ||
Revision as of 19:00, 19 June 2009
|
WikiDoc Resources for Fuller Albright |
|
Articles |
|---|
|
Most recent articles on Fuller Albright Most cited articles on Fuller Albright |
|
Media |
|
Powerpoint slides on Fuller Albright |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Fuller Albright at Clinical Trials.gov Trial results on Fuller Albright Clinical Trials on Fuller Albright at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Fuller Albright NICE Guidance on Fuller Albright
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Fuller Albright Discussion groups on Fuller Albright Patient Handouts on Fuller Albright Directions to Hospitals Treating Fuller Albright Risk calculators and risk factors for Fuller Albright
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Fuller Albright |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Fuller Albright (January 12 1900 – December 8 1969) was an American endocrinologist who made numerous contributions to his field, especially to the area of calcium metabolism.[1]
Education and training
Albright was born in Buffalo, New York. "Fuller" was his mother's maiden name. He entered Harvard College at seventeen. After graduating cum laude three years later he entered Harvard Medical School. While he initially took an interest in obstetrics and orthopedic surgery, the discovery of insulin attracted him to internal medicine, specifically the study of metabolism. After his internship at Massachusetts General Hospital he embarked on a one-year programme of research with Joseph C. Aub, mainly into calcium metabolism and lead poisoning. He was subsequently assistant resident to Dr Warfield Longcope at Johns Hopkins Hospital in Baltimore, where he performed numerous experiments (often without realising their significance), together with his friend John Eager Howard. Finally he spent a year in Vienna with pathologist Prof Jacob Erdheim.[1]
In the early 1930s he returned to Boston, where he became a member of the staff of Massachusetts General Hospital. He married Claire Birge in 1933; they had two sons. At MGH he rapidly developed an endocrinology research group.[1]
Work at MGH
Albright is credited with numerous discoveries in medicine. He described polyostotic fibrous dysplasia (later eponymically called McCune-Albright syndrome), the clinical and pathological features and different types of hyperparathyroidism (excessive production of parathyroid hormone by the parathyroid glands), the mechanism of Cushing's syndrome, renal tubular acidosis (inability of the kidneys to regulate the acid-base balance in the body), and recognised the importance of menopause on osteoporosis.[1] He also delineated forms of congenital adrenal hyperplasia.[2]
He was the president of the American Society for Clinical Investigation (1943-1944), the Association for the Study of Internal Secretions (1945-1946) and the Endocrine Society (1946-1947). In 1955 he was elected to the National Academy of the Sciences.[1]
Illness and death
He developed Parkinson's disease in 1937. By 1956 his symptoms were so intractable that he underwent experimental brain surgery, chemical pallidectomy (obliteration of the globus pallidus by injection of alcohol). The intervention on the right was a success, but the left-sided procedure was complicated by haemorrhage, which left him aphasic and comatose for the remaining 13 years of his life, during which he was nursed at Massachusetts General Hospital.[1]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 Alex Leaf (1976). "Fuller Albright". Biographical Memoirs. Washington, D.C: National Academy Press. pp. 2–23. ISBN 0-30902-349-1.
- ↑ Schwartz TB (1995). "How to learn from patients: Fuller Albright's exploration of adrenal function". Ann. Intern. Med. 123 (3): 225–9. PMID 7598305.